Article Information
History
- December 15, 2021.
Article Versions
- Version 1 (December 14, 2021 - 01:31).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ana Florea, PhD1,*,
- Lina S. Sy, MPH1,#,
- Yi Luo, PhD1,
- Lei Qian, PhD1,
- Katia J. Bruxvoort, PhD1,2,
- Bradley K. Ackerson, MD1,
- Gina S. Lee, MPH1,
- Jennifer H. Ku, PhD1,
- Julia E. Tubert, MPH1,
- Yun Tian, MS1,
- Carla A. Talarico3 and
- Hung Fu Tseng, PhD1,4
- 1Department of Research and Evaluation, Kaiser Permanente Southern California, 100 S Los Robles, Pasadena, CA 91101, USA
- 2Department of Epidemiology, University of Alabama at Birmingham, 1665 University Blvd, Birmingham, AL 35233, USA
- 3Moderna Inc., 200 Technology Square, Cambridge, MA, 02139, USA
- 4Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, 98 S. Los Robles Ave., Pasadena, CA 91101, USA
- ↵*Corresponding Author:
Ana Florea, PhD, MPH, Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S Los Robles, Pasadena, CA 91101, Email: ana.florea{at}kp.org - ↵#Alternate Corresponding Author:
Lina S. Sy, MPH, Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S Los Robles, Pasadena, CA 91101, Email: lina.s.sy{at}kp.org
Posted December 15, 2021.
Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study
